期刊文献+

对一例急性弥漫性腹膜炎病人初始抗感染治疗的分析与评价

Analysis and evaluation of the initial anti-infective treatment of a patient with acute diffuse peritonitis
下载PDF
导出
摘要 目的:通过对1例急性弥漫性腹膜炎病人的初始抗感染治疗方案进行分析与评价,探讨临床药师在药物治疗中发挥的作用。方法:对该病人的初始抗感染治疗方案,从抗菌药物的选择、用法用量、用药时机及疗程、药品费用等多角度分析其合理性。结果:不必要的抗菌药物联用、用法用量不适宜、用药疗程过长、选药不经济是抗感染用药常见的问题。结论:临床药师融入临床开展药学服务,及时发现并协助解决用药问题,对于保障病人安全、有效、经济用药有很好的作用。 Objective: To analyze and evaluate the initial anti-infective treatment regimen of a patient with acute diffuse peritonitis,and discuss the role of clinical pharmacists in drug therapy. Methods: Rationality of the initial anti-infective treat- ment regimen was analyzed from multiple perspectives, the choice of antimicrohials, usage and dosage, time and course of medi- cation, drug cost,etc. Results: Unnecessary combination of antimicrobials,inappropriate usage and dosage,excessive course of treatment, and uneconomical drug choice were common problems in anti-infective drug treatment. Conclusion: Clinical pharma- cists' involvement in clinical pharmaceutical care could timely find out and help to solve the problems encountered in clinical medication, which would ultimately ensure patient safety, treatment efficacy and reduction of drug cost.
作者 苏云霞 丁楠
出处 《药学服务与研究》 CAS 2015年第4期254-256,共3页 Pharmaceutical Care and Research
关键词 临床药师 腹膜炎 弥漫性 抗感染药/药物疗法 药学服务 clinical pharmacists peritonitis,diffuse anti-infective agents/drug therapy pharmaceutical care
  • 相关文献

参考文献6

二级参考文献48

  • 1张军民,周贵民.厌氧菌血培养仍是值得重视的问题[J].中华检验医学杂志,2005,28(10):979-980. 被引量:23
  • 2席玉胜,魏春霞,孟猛,谢潮鑫,陈莉文.依曲康唑对院内继发深部真菌感染的预防作用[J].中国药师,2006,9(6):548-549. 被引量:1
  • 3谢涛.厌氧菌感染与防治[J].现代医药卫生,2007,23(8):1188-1188. 被引量:4
  • 4Marshall J C.IntraK-abdominal infections[J].Microbes Infect,2004,6(11):1015-25.
  • 5Sotto A,Lefrant J Y,Fabbro-Peray P,et al.Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis[J].J Antimicrob Chemother,2002,50(4):569-76.
  • 6Eagye K J,Kuti J L,Dowzicky M,et al.Empiric therapy for secondary peritonitis:a pharmacodynamic analysis of cefepime,ceftazidime,ceftriaxone,imipenem,levofloxacin,piperacillin/tazobactam,and tigecycline using Monte Carlo simulation[J].Clin Ther,2007,29(5):889-99.
  • 7Lin W J,Lo W T,Chu C C,et al.Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infection in children[J].J Microbiol Immunol Infect,2006,39(3):249-54.
  • 8Sturkenboom M C,Goettsch W G,Picelli G,et al.Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs[J].Br J Clin Pharmacol,2005,60(4):438-43.
  • 9Steinkraus G,White R,Friedrich L.Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA),vancomycin-susceptible clinical methicillin-resistant S.aureus (MRSA) blood isolates from 2001-05[J].J Antimicrob Chemother,2007,60(4):788-94.
  • 10Szeto C C,Kwan B C,Chow K M,et al.Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients:review of 232 consecutive cases[J].Clin J Am Soc Nephrol,2008,3(1):91-7.

共引文献272

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部